Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients
Purpose: To assess whether contralateral parenchymal enhancement (CPE) on MRI is associated with gene expression pathways in ER+/HER2-breast cancer, and if so, whether such pathways are related to survival. Methods: Preoperative breast MRIs were analyzed of early ER+/HER2-breast cancer patients elig...
Guardado en:
Autores principales: | Max A.A. Ragusi, Tycho Bismeijer, Bas H.M. van der Velden, Claudette E. Loo, Sander Canisius, Jelle Wesseling, Lodewyk F.A. Wessels, Sjoerd G. Elias, Kenneth G.A. Gilhuijs |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7a1e711194c46f9bfc41983bd3be40b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interactive Hepatic Parenchymal Transection Simulation with Haptic Feedback
por: Hongyu Wu, et al.
Publicado: (2021) -
A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes
por: Alexander Burov, et al.
Publicado: (2021) -
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
por: Jinhai Wang, et al.
Publicado: (2021) -
Purification and characterization of an aspartic protease from the Rhizopus oryzae protease extract, Peptidase R
por: Hsiao,Nai-Wan, et al.
Publicado: (2014) -
Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
por: Shansa Pranami E. Jayaweera, et al.
Publicado: (2021)